OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9942	Companies
201095	Keywords
131819	Articles
106840	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 1 month ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
PRESS RELEASE

published on 01/13/2025 at 18:00, 1 year 1 month ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 4 obligations convertibles en Oxurion pour une augmentation de capital de 100 000 EUR, soutenant le développement de médicaments pour préserver la vision des personnes âgées

Obligations Convertibles Augmentation De Capital Atlas Special Opportunities Médicaments Innovants Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 1 month ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF

published on 01/06/2025 at 18:05, 1 year 1 month ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 1 month ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
PRESS RELEASE

published on 01/06/2025 at 18:00, 1 year 1 month ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities LLC regarding ownership of 624,817 shares, exceeding the 15% threshold

Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Ophthalmological Therapies
BRIEF

published on 01/03/2025 at 18:05, 1 year 1 month ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
BRIEF

published on 01/03/2025 at 18:05, 1 year 1 month ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Actions Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 1 month ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities

Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
PRESS RELEASE

published on 01/03/2025 at 18:00, 1 year 1 month ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV announces receipt of transparency notification regarding shareholding. Bio-pharmaceutical company developing ophthalmological therapies. Refer to website for more details

Transparency Notification Shareholding Belgium Oxurion NV Ophthalmological Therapies

Accesswire

Published on 02/28/2026 at 10:00, 22 hours 14 minutes ago

Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 03:00, 1 day 5 hours ago

Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 1 day 6 hours ago

Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 1 day 8 hours ago

Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/28/2026 at 00:00, 1 day 8 hours ago

GECC Reports Director Election Results

View all ACCESSWIRE

EQS Group

Published on 02/28/2026 at 21:50, 10 hours 24 minutes ago

CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BSL RENDITION OF "YOU'LL NEVER WALK ALONE"
Published on 02/28/2026 at 21:20, 10 hours 54 minutes ago

Huawei's SuperPoD Portfolio Creates New Option for Global Computing at MWC Barcelona 2026
Published on 02/28/2026 at 21:00, 11 hours 14 minutes ago

CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BRITISH SIGN LANGUAGE RENDITION OF 'YOU'LL NEVER WALK ALONE'
Published on 02/28/2026 at 19:15, 12 hours 59 minutes ago

Athletes from Sweden and the Netherlands Win Medals at the Olympic Winter Games Milano Cortina 2026 as Team TCL Ambassador Reaches the Podium
Published on 02/28/2026 at 16:55, 15 hours 19 minutes ago

CGTN: How China's path of democracy safeguards people's rights and interests

Les Echos

Published on 02/27/2026 at 23:12, 1 day 9 hours ago

ENGIE - Résultats ABB
Published on 02/27/2026 at 23:00, 1 day 9 hours ago

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 23:00, 1 day 9 hours ago

Biophytis porte à 2 m€ le plafond de sa ligne obligataire avec Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day 14 hours ago

AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 18:02, 1 day 14 hours ago

AXA: Conclusion d’une convention de rachat d’actions dans le cadre du programme de rachat d’actions d’AXA

View all LES ECHOS COMFI WIRE